Search research articles
Contact Us
Filters
Showing results (51-60 of 137) with videos related to
Page
of 14
Sort By:
BMJ (Clinical Research Ed.)
|
December 14, 2023
Projecting complete redaction of clinical trial protocols (RAPTURE): redacted cross sectional study
Nir Balaban, Ghulam Rehman Mohyuddin, Adi Kashi, et al.
Military Medicine
|
October 17, 2007
Mobile chemical detector (AP2C+SP4E) as an aid for medical decision making in the battlefield
Arik Eisenkraft, Gal Markel, Shirley Simovich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 10, 2004
The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells
Gal Markel, Raizy Gruda, Hagit Achdout, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 11, 2016
Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating Lymphocytes
Ronny Ben-Avi, Orit Itzhaki, David Simansky, et al.
European Journal of Immunology
|
November 24, 2007
Manipulation of NK cytotoxicity by the IAP family member Livin
Boaz Nachmias, Sa'ar Mizrahi, Meital Elmalech, et al.
Archives of Dermatological Research
|
April 2, 2013
Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes
Malka Hochberg, Leon Gilead, Gal Markel, et al.
The Israel Medical Association Journal : IMAJ
|
November 9, 2007
Osmium tetroxide: a new kind of weapon
Igor Makarovsky, Gal Markel, Azik Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2002
Characterization of the expression of MHC proteins in human embryonic stem cells
Micha Drukker, Gil Katz, Achia Urbach, et al.
Aesthetic Plastic Surgery
|
May 20, 2016
Adipocytes Viability After Suction-Assisted Lipoplasty: Does the Technique Matter?
Moti Harats, Eran Millet, Marie Jaeger, et al.
Frontiers in Immunology
|
November 1, 2017
Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor
Vasyl Eisenberg, Katerina Shamalov, Shimrit Meir, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 137) with videos related to
Sort By:
Page
of 14
BMJ (Clinical Research Ed.)
|
December 14, 2023
Projecting complete redaction of clinical trial protocols (RAPTURE): redacted cross sectional study
Nir Balaban, Ghulam Rehman Mohyuddin, Adi Kashi, et al.
Military Medicine
|
October 17, 2007
Mobile chemical detector (AP2C+SP4E) as an aid for medical decision making in the battlefield
Arik Eisenkraft, Gal Markel, Shirley Simovich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 10, 2004
The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells
Gal Markel, Raizy Gruda, Hagit Achdout, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 11, 2016
Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating Lymphocytes
Ronny Ben-Avi, Orit Itzhaki, David Simansky, et al.
European Journal of Immunology
|
November 24, 2007
Manipulation of NK cytotoxicity by the IAP family member Livin
Boaz Nachmias, Sa'ar Mizrahi, Meital Elmalech, et al.
Archives of Dermatological Research
|
April 2, 2013
Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes
Malka Hochberg, Leon Gilead, Gal Markel, et al.
The Israel Medical Association Journal : IMAJ
|
November 9, 2007
Osmium tetroxide: a new kind of weapon
Igor Makarovsky, Gal Markel, Azik Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2002
Characterization of the expression of MHC proteins in human embryonic stem cells
Micha Drukker, Gil Katz, Achia Urbach, et al.
Aesthetic Plastic Surgery
|
May 20, 2016
Adipocytes Viability After Suction-Assisted Lipoplasty: Does the Technique Matter?
Moti Harats, Eran Millet, Marie Jaeger, et al.
Frontiers in Immunology
|
November 1, 2017
Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor
Vasyl Eisenberg, Katerina Shamalov, Shimrit Meir, et al.
Page
of 14